Device/Diagnostics Quarterly Dealmaking Statistics, Q3 2019
A Look At The Financing, M&A And Alliance Activity In July–September 2019
Device financing increased substantially in Q3, thanks to debt raises led by Insulet. Acquisition dollar volume dropped, though, but Siemens' buy of Corindus for $1.1bn was a stand-out. Diagnostics/research tools financing dropped by 28% from Q2, while acquisition value greatly increased due to Exact Sciences' $2.8bn purchase of Genomic Health.